Literature DB >> 20596243

Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Karthik Raman1, Balagurunathan Kuberan.   

Abstract

Heparan sulfate proteoglycans (HSPGs) play vital roles in every step of tumor progression allowing cancer cells to proliferate, escape from immune response, invade neighboring tissues, and metastasize to distal sites away from the primary site. Several cancers including breast, lung, brain, pancreatic, skin, and colorectal cancers show aberrant modulation of several key HS biosynthetic enzymes such as 3-O Sulfotransferase and 6-O Sulfotransferase, and also catabolic enzymes such as HSulf-1, HSulf-2 and heparanase. The resulting tumor specific HS fine structures assist cancer cells to breakdown ECM to spread, misregulate signaling pathways to facilitate their proliferation, promote angiogenesis to receive nutrients, and protect themselves against natural killer cells. This review focuses on the changes in the expression of HS biosynthetic and catabolic enzymes in several cancers, the resulting changes in HS fine structures, and the effects of these tumor specific HS signatures on promoting invasion, proliferation, and metastasis. It is possible to retard tumor progression by modulating the deregulated biosynthetic and catabolic pathways of HS chains through novel chemical biology approaches.

Entities:  

Year:  2010        PMID: 20596243      PMCID: PMC2892923          DOI: 10.2174/187231310790226206

Source DB:  PubMed          Journal:  Curr Chem Biol        ISSN: 1872-3136


  152 in total

1.  Characterization of a heparan sulfate 3-O-sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide.

Authors:  Hideo Mochizuki; Keiichi Yoshida; Masanori Gotoh; Shigemi Sugioka; Norihiro Kikuchi; Yeon-Dae Kwon; Akira Tawada; Kennichi Maeyama; Niro Inaba; Toru Hiruma; Koji Kimata; Hisashi Narimatsu
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

Review 2.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

3.  The chondroitin 4-sulfate-protein linkage.

Authors:  U Lindahl; L Rodén
Journal:  J Biol Chem       Date:  1966-05-10       Impact factor: 5.157

4.  Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase.

Authors:  Y Naparstek; I R Cohen; Z Fuks; I Vlodavsky
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

Review 5.  Matrix-degrading metalloproteinases in tumor progression.

Authors:  L M Matrisian; J Wright; K Newell; J P Witty
Journal:  Princess Takamatsu Symp       Date:  1994

6.  Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.

Authors:  J Liu; N W Shworak; P Sinaÿ; J J Schwartz; L Zhang; L M Fritze; R D Rosenberg
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

7.  Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.

Authors:  Martha L Escobar Galvis; Juan Jia; Xiao Zhang; Nadja Jastrebova; Dorothe Spillmann; Eva Gottfridsson; Toin H van Kuppevelt; Eyal Zcharia; Israel Vlodavsky; Ulf Lindahl; Jin-Ping Li
Journal:  Nat Chem Biol       Date:  2007-10-21       Impact factor: 15.040

Review 8.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

9.  Structure of the heparan sulfate-protein linkage region. Demonstration of the sequence galactosyl-galactosyl-xylose-2-phosphate.

Authors:  L A Fransson; I Silverberg; I Carlstedt
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

10.  Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.

Authors:  Kazuaki Miyamoto; Kiyoshi Asada; Takashi Fukutomi; Eriko Okochi; Yukiko Yagi; Tadashi Hasegawa; Toshimasa Asahara; Takashi Sugimura; Toshikazu Ushijima
Journal:  Oncogene       Date:  2003-01-16       Impact factor: 9.867

View more
  37 in total

Review 1.  Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects.

Authors:  Amy A Baxter; Fung T Lay; Ivan K H Poon; Marc Kvansakul; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

2.  Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis.

Authors:  Karthik Raman; Masayuki Ninomiya; Thao Kim Nu Nguyen; Yasuhiro Tsuzuki; Mamoru Koketsu; Balagurunathan Kuberan
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

3.  Discovery of novel sulfonated small molecules that inhibit vascular tube formation.

Authors:  Karthik Raman; Rajesh Karuturi; Vimal P Swarup; Umesh R Desai; Balagurunathan Kuberan
Journal:  Bioorg Med Chem Lett       Date:  2012-04-16       Impact factor: 2.823

4.  Differential effects of Heparitinase I and Heparitinase III on endothelial tube formation in vitro.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Biochem Biophys Res Commun       Date:  2010-06-17       Impact factor: 3.575

Review 5.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

6.  Hydrogen/deuterium exchange-LC-MS approach to characterize the action of heparan sulfate C5-epimerase.

Authors:  Ponnusamy Babu; Xylophone V Victor; Emily Nelsen; Thao Kim Nu Nguyen; Karthik Raman; Balagurunathan Kuberan
Journal:  Anal Bioanal Chem       Date:  2011-05-15       Impact factor: 4.142

7.  Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.

Authors:  Rachel K Okolicsanyi; Andre J van Wijnen; Simon M Cool; Gary S Stein; Lyn R Griffiths; Larisa M Haupt
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

8.  Investigating the mechanism of the assembly of FGF1-binding heparan sulfate motifs.

Authors:  Thao Kim Nu Nguyen; Karthik Raman; Vy My Tran; Balagurunathan Kuberan
Journal:  FEBS Lett       Date:  2011-07-26       Impact factor: 4.124

9.  Characterization of uniformly and atom-specifically (13)C-labeled heparin and heparan sulfate polysaccharide precursors using (13)C NMR spectroscopy and ESI mass spectrometry.

Authors:  Thao K N Nguyen; Vy M Tran; Xylophone V Victor; Jack J Skalicky; Balagurunathan Kuberan
Journal:  Carbohydr Res       Date:  2010-08-21       Impact factor: 2.104

Review 10.  Applications of isotopes in advancing structural and functional heparanomics.

Authors:  Vy M Tran; Thao K N Nguyen; Karthik Raman; Balagurunathan Kuberan
Journal:  Anal Bioanal Chem       Date:  2010-09-14       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.